跳到正文
原文
STAT· @statnews · X·· 1 天前AI 评分42
AI 导读

凭借1.73亿美元,Marrow Therapeutics正试图开发一种与基因疗法同样有效的注射疗法,以应对镰状细胞病 https://www.statnews.com/2026/11/17/new-startup-developing-novel-sickle-cell-anemia-infusion-no-gene-therapy/

正文

With $173 million, Marrow Therapeutics is trying to build an injection as effective as gene therapy to tackle sickle cell disease https://www.statnews.com/2026/11/17/new-startup-developing-novel-sickle-cell-anemia-infusion-no-gene-therapy/

来源:STAT · x.com